• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of permeation enhancers BL-9 and Brij-78 on absorption of four peptide eyedrops in rabbits.

作者信息

Chiou G C, Shen Z F, Li B H

机构信息

Department of Medical Pharmacology and Toxicology, College of Medicine, Texas A&M University, College Station 77843.

出版信息

Zhongguo Yao Li Xue Bao. 1992 May;13(3):201-5.

PMID:1442098
Abstract

Systemic absorption of 4 peptide drugs through ocular route was enhanced by permeation enhancers, BL-9 and Brij-78. Gonadorelin (LHRH) was the smallest molecule (M(r) = 1200) and its systemic delivery was most efficiently enhanced by BL-9 (17.0-20.8 times) and Brij-78 (13.9-21.5 times). Although bombesin (M(r) = 1620), atrial natriuretic peptides (ANP) (M(r) = 3240), and adrenocorticotropic hormone (ACTH) (M(r) = 4540) had molecular weight ranged widely, their systemic absorption through ocular route was enhanced by BL-9 (6.1-8.3 times) and Brij-78 (6.5-9.0 times) in about the same degree. BL-9 enhanced systemic absorption of peptide drugs faster and reached peak peptide concentrations in 5-20 min. On the other hand, Brij-78 took 20-60 min to reach to peak concentration of peptide drugs in the blood. These results indicate that systemic delivery of peptide drug through ocular route is a feasible one particularly when the absorption enhancers are used.

摘要

相似文献

1
Effects of permeation enhancers BL-9 and Brij-78 on absorption of four peptide eyedrops in rabbits.
Zhongguo Yao Li Xue Bao. 1992 May;13(3):201-5.
2
Enhancement of systemic delivery of met-enkephalin and leu-enkephalin eyedrops with permeation enhancers.
Methods Find Exp Clin Pharmacol. 1992 Jun;14(5):361-6.
3
Feasibility of glucagon eyedrops for clinical use in hypoglycemia.胰高血糖素滴眼液用于临床低血糖症的可行性。
J Ocul Pharmacol Ther. 1995 Fall;11(3):279-82. doi: 10.1089/jop.1995.11.279.
4
Adjustment of blood sugar levels with insulin and glucagon eyedrops in normal and diabetic rabbits.
J Ocul Pharmacol. 1990 Fall;6(3):233-41. doi: 10.1089/jop.1990.6.233.
5
Chronic systemic delivery of insulin through the ocular route.通过眼部途径进行胰岛素的慢性全身给药。
J Ocul Pharmacol. 1993 Spring;9(1):85-90. doi: 10.1089/jop.1993.9.85.
6
Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation.促性腺激素释放激素的口腔黏膜给药:控释及增强黏膜渗透的药代动力学研究
Pharm Dev Technol. 1996 Oct;1(3):251-9. doi: 10.3109/10837459609022593.
7
Systemic administration of calcitonin through ocular route.
Life Sci. 1992;50(5):349-54. doi: 10.1016/0024-3205(92)90436-s.
8
Delivery of systemic regular insulin via the ocular route in cats.通过眼部途径在猫体内递送全身性常规胰岛素。
J Ocul Pharmacol Ther. 1995 Winter;11(4):565-73. doi: 10.1089/jop.1995.11.565.
9
Modification of ocular permeability of peptide drugs by absorption promoters.吸收促进剂对肽类药物眼部通透性的改善
Biol Pharm Bull. 2000 Dec;23(12):1524-7. doi: 10.1248/bpb.23.1524.
10
Feasibility of insulin eyedrops for human use.供人类使用的胰岛素眼药水的可行性。
J Ocul Pharmacol. 1994 Fall;10(3):587-90. doi: 10.1089/jop.1994.10.587.